Try a new search

Format these results:

Searched for:



Total Results:


Acute Necrotizing Pancreatitis following Long-Term Antipsychotic Use [Case Report]

Liebers, David T; Ofomata, Adaora; Badolato, Ryan; Mills, Emily; Farahmand, Pantea
PMID: 34504720
ISSN: 2090-682x
CID: 5012062

Nitrous Oxide Inhalant Use Disorder Preceding Symptoms Concerning for Primary Psychotic Illness [Meeting Abstract]

Roberts, Daniel; Farahmand, Pantea; Wolkin, Adam
ISSN: 1055-0496
CID: 5232412

Systemic racism and substance use disorders

Farahmand, Pantea; Arshed, Arslaan; Bradley, Mark V.
Increasing attention to systemic racism in the United States in all aspects of life has sharpened focus on its effects on the health outcomes of Black, Latinx, and Indigenous populations. Racial disparities in substance use disorders remain a significant public health problem in mental health, and psychiatrists require sufficient knowledge and awareness to help address these disparities. First, this article reviews evidence of racial disparities in substance use disorders. We then discuss the historical and legal foundations of systemic racism and substance use disorder disparities and explore research examining the role of systemic racism in substance use disorder outcomes on structural and individual levels. Finally, we discuss recommendations for providing substance use disorder care in a more racially equitable manner.
ISSN: 0048-5713
CID: 4683172

Nitrous Oxide Inhalant Use Disorder Preceding Symptoms Concerning for Primary Psychotic Illness [Case Report]

Roberts, Daniel; Farahmand, Pantea; Wolkin, Adam
BACKGROUND AND OBJECTIVE/OBJECTIVE:Nitrous oxide has long been used recreationally for its ability to induce euphoria and other deliriant effects. In modern times, it remains a popular, legal, and widely available option for those seeking altered states. Though substance-induced psychotic symptoms have been mentioned in the literature, the potential long-term negative neuropsychiatric effects related to its use have not been well established. METHODS AND RESULTS/RESULTS:This is a patient case report of a young man (N = 1) who initially presented with acute neurological symptoms requiring hospitalization due to heavy nitrous oxide inhalant use, and went on to present with symptoms concerning for a primary psychotic illness over multiple inpatient admissions. He provided both verbal and written consent to share his story for this case report. DISCUSSION AND CONCLUSIONS/CONCLUSIONS:It is important to consider nitrous oxide use as a possible contributing factor to the development of primary psychotic illness. SCIENTIFIC SIGNIFICANCE/CONCLUSIONS:deficiency. Here, we present a patient with risk factors for psychotic illness developing psychotic illness following extensive nitrous oxide use. This report offers a unique perspective of longitudinal follow-up (often not provided with reports on this topic), and illustrates the importance of healthcare providers inquiring about nitrous oxide abuse in patients presenting with early psychotic symptoms. (Am J Addict 2020;00:00-00).
PMID: 32333625
ISSN: 1521-0391
CID: 4411622

Subcutaneous Buprenorphine for a Patient With a History of Misusing an Indwelling Catheter: AÂ Case Report

Farahmand, Pantea; Kim, Jungjin; Twark, Claire; Suzuki, Joji
PMID: 31629483
ISSN: 1545-7206
CID: 4181572

An Impaired Physician with Alcohol Use Disorder and Multiple Medical Comorbidities

Hsu, Michael; Farahmand, Pantea; Baslet, Gaston; Sanchez, Luis; Levy-Carrick, Nomi C; Suzuki, Joji
PMID: 32287085
ISSN: 1465-7309
CID: 4383332

Symposia, Case Conference, and Medical Update

[Anton, Raymond; Falk, Daniel; O'Malley, Stephanie; Silvermand, Bernard; Farahmand, Pantea; Sherer, James; Greenfield, Shelly; Rosa, Carmen; Barbosa-Leiker, Celestina; Campbell, Aimee; McHugh, Kathryn; Guille, Constance; Ouseph, Rita; Sise, Robert]
"Harm Reduction as a Goal in AUD Pharmacotherapy — Role for the WHO Risk Drinking Category Change -- Opioid Use Disorder in Women: Evidence from the National Institute on Drug Abuse Clinical Trials Network (CTN) and the Implications for Treatment
PMID: 31095828
ISSN: 1521-0391
CID: 4335372

Prescribing Opioid Replacement Therapy in U.S. Correctional Settings

Farahmand, Pantea; Modesto-Lowe, Vania; Chaplin, Margaret M
Opioid addiction is a chronic, relapsing disorder associated with criminality, unemployment, infectious diseases, and legal problems. Such addictions are typically over-represented in correctional populations. Inmates with untreated opioid addiction often relapse shortly after release into the community, thereby increasing the risk of overdose, serious illnesses (HIV, hepatitis C) and psychosocial problems (e.g., crimes, recidivism, and reincarceration). There are three U.S. Food and Drug Administration-approved medications for the treatment of opioid use disorder: methadone, buprenorphine, and naltrexone. Opioid replacement therapies (ORTs) are associated with significant benefits, including reducing the incidences of HIV, criminality, and opioid-related mortality. However, most opioid-dependent Americans who are incarcerated are forced to discontinue ORT upon prison entry. This article offers a rationale for providing ORT to addicted prisoners while incarcerated and providing appointments with outpatient providers for continued treatment.
PMID: 29282239
ISSN: 1943-3662
CID: 4181602

Psychotherapy for Adolescents With Attention-Deficit Hyperactivity Disorder: A Pediatrician's Guide

Modesto-Lowe, Vania; Charbonneau, Victoria; Farahmand, Pantea
Attention-deficit hyperactivity disorder (ADHD) presents with high levels of inattention, impulsiveness, and hyperactivity. ADHD starts in childhood and results in impairments that continue into adulthood. ADHD symptoms lead to decreased functionality in various life domains and result in poor academics, behavioral challenges, delayed independence, and strained relationships. Despite advances in diagnosis and treatment, persistent residual symptoms are common, highlighting the need for novel treatment strategies. This article aims to provide a review of the psychotherapeutic interventions available for teens that receive pharmacotherapy but continue to struggle with the residual symptoms of ADHD that interfere with academic function, relationship formation, and psychological development.
PMID: 27895149
ISSN: 1938-2707
CID: 4181592

New Onset Seizure Disorder Following Electroconvulsive Therapy [Case Report]

Selvadurai, Chindhuri; Farahmand, Pantea; Jain, Naha; Alvarado, Camille
Electroconvulsive therapy (ECT) is an effective treatment for many psychiatric illnesses including refractory depression, catatonia, bipolar disorder, and schizophrenia, along with neuropsychiatric diseases such as dementia and Parkinson's disease. The emergence of a seizure disorder after the initiation of ECT is a rare but severe occurrence. It can become challenging for clinicians to determine whether ECT should be continued. We present a case of a 73-year-old female with schizoaffective disorder who received a total of 173 ECT treatments over the course of five years for breakthrough psychosis due to medication nonadherence. After five years of treatment, she experienced her first episode of tonic-clonic seizure activity. We review the current evidence and discuss factors that should be considered when treating such an individual.
PMID: 29782784
ISSN: 0010-6178
CID: 4181612